Literature DB >> 9447502

Pilot study of haloperidol, fluoxetine, and placebo for agitation in Alzheimer's disease.

A P Auchus1, C Bissey-Black.   

Abstract

This pilot study compared haloperidol, fluoxetine, and placebo for reduction of agitation in 15 outpatients with AD. The two drugs were no more effective than placebo at reducing agitation in these subjects; however, both drugs produced more toxicity than did placebo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9447502     DOI: 10.1176/jnp.9.4.591

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  16 in total

Review 1.  Pharmacological treatment of psychosis and agitation in elderly patients with dementia: four decades of experience.

Authors:  Sandra S Kindermann; Christian R Dolder; Anne Bailey; Ira R Katz; Dilip V Jeste
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

2.  Sexually inappropriate behaviour in demented elderly people.

Authors:  K Alagiakrishnan; D Lim; A Brahim; A Wong; A Wood; A Senthilselvan; W T Chimich; L Kagan
Journal:  Postgrad Med J       Date:  2005-07       Impact factor: 2.401

Review 3.  Update on SSRI Treatment for Neuropsychiatric Symptoms of Dementia.

Authors:  James M Wilkins; Brent P Forester
Journal:  Curr Psychiatry Rep       Date:  2016-02       Impact factor: 5.285

Review 4.  Antipsychotics for behavioural and psychological problems in elderly people with dementia: a systematic review of adverse events.

Authors:  Marianne B van Iersel; Sytse U Zuidema; Raymond T C M Koopmans; Frans R J Verhey; Marcel G M Olde Rikkert
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 5.  Management of neuropsychiatric symptoms in people with dementia.

Authors:  Clive Ballard; Anne Corbett
Journal:  CNS Drugs       Date:  2010-09       Impact factor: 5.749

Review 6.  Does pharmacological treatment of neuropsychiatric symptoms in Alzheimer's disease relieve caregiver burden?

Authors:  Karen Levy; Krista L Lanctôt; Shale B Farber; Abby Li; Nathan Herrmann
Journal:  Drugs Aging       Date:  2012-03-01       Impact factor: 3.923

Review 7.  Pharmacological treatment of the psychosis of Alzheimer's disease: what is the best approach?

Authors:  Subramoniam Madhusoodanan; Payal Shah; Ronald Brenner; Sanjay Gupta
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 8.  Therapeutic potential of fluoxetine in neurological disorders.

Authors:  Jop P Mostert; Marcus W Koch; Marco Heerings; Dorothea J Heersema; Jacques De Keyser
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

9.  Drug therapy for delirium in terminally ill adults.

Authors:  Anne M Finucane; Louise Jones; Baptiste Leurent; Elizabeth L Sampson; Patrick Stone; Adrian Tookman; Bridget Candy
Journal:  Cochrane Database Syst Rev       Date:  2020-01-21

10.  Pharmacological treatments for alleviating agitation in dementia: a systematic review and network meta-analysis.

Authors:  Khachen Kongpakwattana; Ratree Sawangjit; Itthipol Tawankanjanachot; J Simon Bell; Sarah N Hilmer; Nathorn Chaiyakunapruk
Journal:  Br J Clin Pharmacol       Date:  2018-05-14       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.